January 1, 2018 Development of a symptom-focused patient-reported outcome measure for functional dyspepsia: the Functional Dyspepsia Symptom Diary (FDSD)
December 22, 2017 Qualitative Development and Cognitive Evaluation of the Symptoms of Major Depressive Disorder (S-MDD), A Consortium-Developed Patient Reported Outcome Measure
December 18, 2017 C-Path receives COA qualification from FDA for the Symptoms of Major Depressive Disorder Scale (SMDDS) Tucson, AZ – December 18, 2017 Critical Path Institute‘s (C-Path) Patient-Reported Outcome (PRO) Consortium annou
January 12, 2017 Emerging Good Practices for Translatability Assessment (TA) of Patient-Reported Outcome (PRO) Measures
January 12, 2017 Patient-Reported Outcome (PRO) Consortium Translation Process: Consensus Development of Updated Best Practices
June 6, 2017 Selection of and Evidentiary Considerations for Wearable Devices and Their Measurements for Use in Regulatory Decision Making: Recommendations from the ePRO Consortium This webinar provides a recommended framework for the selection and evaluation of wearable devices and their measurements for use
May 31, 2017 Development of a Harmonized Patient-Reported Outcome Questionnaire to Assess Myelofibrosis Symptoms in Clinical Trials
April 26, 2017-April 27, 2017 Eighth Annual Patient-Reported Outcome Consortium Workshop April 26 – 27, 2017 Hyatt Regency Bethesda, 1 Bethesda Metro Center, Bethesda, MD 20814 On April 26-27, 2017 the EIGHTH ANNUAL P
April 21, 2017 Development of the Diary for Irritable Bowel Syndrome Symptoms (DIBSS) to Assess Treatment Benefit in Clinical Trials: Foundational Qualitative Research
February 28, 2017 Considerations for Requiring Subjects to Respond to PRO Instruments Collected Electronically This webinar provides an overview of specific considerations related to allowing subjects to opt out of responding to individual i
